Related Experiment Video
Updated: Jun 16, 2026
08:46
Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis
Published on: August 26, 2020
Kalirin: a novel genetic risk factor for ischemic stroke
Tiago Krug1, Helena Manso, Liliana Gouveia
1Instituto Gulbenkian de Ciência, Oeiras, Portugal.
Human Genetics
|January 29, 2010
Summary
Genetic variants in the Kalirin (KALRN) gene region are associated with an increased risk of ischemic stroke. This finding suggests KALRN may be a common genetic risk factor for various vascular diseases.
Area of Science:
- Genetics
- Neurology
- Cardiology
Background:
- Cerebrovascular and cardiovascular diseases are leading global causes of death and disability.
- These complex disorders arise from genetic and environmental interactions, potentially sharing susceptibility genes.
- Previous studies linked Kalirin (KALRN) gene variants to cardiovascular and metabolic conditions, but not stroke.
Purpose of the Study:
- To investigate if single nucleotide polymorphisms (SNPs) in the KALRN gene region on chromosome 3q13 predispose individuals to ischemic stroke (IS).
- To examine the association between SNPs in the KALRN and Ropporin (ROPN1) genes and IS risk in a Portuguese cohort.
Main Methods:
- Genotyped 34 tagging SNPs in the KALRN and ROPN1 region in 565 IS patients and 517 controls.
- Performed genotype imputation for 405 additional markers on chromosome 3.
- Tested single-marker association with IS risk, adjusting for hypertension, diabetes, and smoking status.
Main Results:
- One intergenic SNP (rs4499545) and two KALRN SNPs (rs17286604, rs11712619) showed significant association with IS risk (P < 0.05).
- Thirty-two imputed SNPs also demonstrated association, with three validated through genotyping (rs7620580, rs6438833, rs11712039).
- SNP rs11712039's association with IS was further supported by a previous genome-wide association study.
Conclusions:
- Variants within the KALRN gene region are identified as risk factors for ischemic stroke.
- The KALRN gene may represent a shared genetic risk factor for multiple vascular diseases.
- This study highlights the role of KALRN in cerebrovascular disease susceptibility.
Related Concept Videos
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...